Misoprostol in Office Hysteroscopy and Endometrial Biopsy
Status:
Withdrawn
Trial end date:
2020-03-25
Target enrollment:
Participant gender:
Summary
We hypothesize that use of vaginal misoprostol will help in reducing the pain scores when
used prior to concurrent office hysteroscopy and endometrial biopsy in a particular subgroup
of women who are anticipated to require cervical dilatation.